All of Tm's genetic tests use its Tag-It Universal Array platform. Tm's assays, meantime, use Luminex's xMAP platform.
The original agreement between the two companies, launched in 2001, expired yesterday. The renegotiated deal incorporates "similar terms" to the original, including the ability for Tm to distribute such xMAP systems as the new LX200 instrument, Tm said.
Financial terms of the deal were not disclosed.